CME Group Statistics
Total Valuation
CME Group has a market cap or net worth of $98.72 billion. The enterprise value is $100.39 billion.
| Market Cap | 98.72B |
| Enterprise Value | 100.39B |
Important Dates
The last earnings date was Wednesday, July 23, 2025, before market open.
| Earnings Date | Jul 23, 2025 |
| Ex-Dividend Date | Sep 9, 2025 |
Share Statistics
CME Group has 360.38 million shares outstanding. The number of shares has increased by 0.12% in one year.
| Current Share Class | 360.38M |
| Shares Outstanding | 360.38M |
| Shares Change (YoY) | +0.12% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 91.20% |
| Float | 358.84M |
Valuation Ratios
The trailing PE ratio is 26.52 and the forward PE ratio is 24.36. CME Group's PEG ratio is 4.82.
| PE Ratio | 26.52 |
| Forward PE | 24.36 |
| PS Ratio | 15.31 |
| Forward PS | 15.01 |
| PB Ratio | 3.55 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 24.03 |
| P/OCF Ratio | 23.53 |
| PEG Ratio | 4.82 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.08, with an EV/FCF ratio of 24.44.
| EV / Earnings | 26.98 |
| EV / Sales | 15.61 |
| EV / EBITDA | 22.08 |
| EV / EBIT | 23.82 |
| EV / FCF | 24.44 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.82 |
| Debt / FCF | 0.92 |
| Interest Coverage | 25.29 |
Financial Efficiency
Return on equity (ROE) is 13.61% and return on invested capital (ROIC) is 8.36%.
| Return on Equity (ROE) | 13.61% |
| Return on Assets (ROA) | 1.74% |
| Return on Invested Capital (ROIC) | 8.36% |
| Return on Capital Employed (ROCE) | 11.35% |
| Revenue Per Employee | $1.71M |
| Profits Per Employee | $989,734 |
| Employee Count | 3,760 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CME Group has paid $1.08 billion in taxes.
| Income Tax | 1.08B |
| Effective Tax Rate | 22.27% |
Stock Price Statistics
The stock price has increased by +32.59% in the last 52 weeks. The beta is 0.46, so CME Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +32.59% |
| 50-Day Moving Average | 275.84 |
| 200-Day Moving Average | 255.87 |
| Relative Strength Index (RSI) | 43.69 |
| Average Volume (20 Days) | 2,088,540 |
Short Selling Information
The latest short interest is 5.42 million, so 1.50% of the outstanding shares have been sold short.
| Short Interest | 5.42M |
| Short Previous Month | 4.73M |
| Short % of Shares Out | 1.50% |
| Short % of Float | 1.51% |
| Short Ratio (days to cover) | 2.53 |
Income Statement
In the last 12 months, CME Group had revenue of $6.43 billion and earned $3.72 billion in profits. Earnings per share was $10.33.
| Revenue | 6.43B |
| Gross Profit | 6.43B |
| Operating Income | 4.21B |
| Pretax Income | n/a |
| Net Income | 3.72B |
| EBITDA | 4.55B |
| EBIT | 4.21B |
| Earnings Per Share (EPS) | $10.33 |
Balance Sheet
The company has $2.10 billion in cash and $3.77 billion in debt, giving a net cash position of -$1.67 billion or -$4.65 per share.
| Cash & Cash Equivalents | 2.10B |
| Total Debt | 3.77B |
| Net Cash | -1.67B |
| Net Cash Per Share | -$4.65 |
| Equity (Book Value) | 27.74B |
| Book Value Per Share | 77.13 |
| Working Capital | 2.66B |
Cash Flow
In the last 12 months, operating cash flow was $4.20 billion and capital expenditures -$88.60 million, giving a free cash flow of $4.11 billion.
| Operating Cash Flow | 4.20B |
| Capital Expenditures | -88.60M |
| Free Cash Flow | 4.11B |
| FCF Per Share | $11.40 |
Margins
Gross margin is 100.00%, with operating and profit margins of 65.51% and 58.59%.
| Gross Margin | 100.00% |
| Operating Margin | 65.51% |
| Pretax Margin | 75.37% |
| Profit Margin | 58.59% |
| EBITDA Margin | 70.69% |
| EBIT Margin | 65.51% |
| FCF Margin | 63.85% |
Dividends & Yields
This stock pays an annual dividend of $10.80, which amounts to a dividend yield of 3.94%.
| Dividend Per Share | $10.80 |
| Dividend Yield | 3.94% |
| Dividend Growth (YoY) | 9.18% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 103.58% |
| Buyback Yield | -0.12% |
| Shareholder Yield | 3.83% |
| Earnings Yield | 3.77% |
| FCF Yield | 4.16% |
Analyst Forecast
The average price target for CME Group is $261.93, which is -4.38% lower than the current price. The consensus rating is "Hold".
| Price Target | $261.93 |
| Price Target Difference | -4.38% |
| Analyst Consensus | Hold |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 4.51% |
| EPS Growth Forecast (5Y) | 8.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 23, 2012. It was a forward split with a ratio of 5:1.
| Last Split Date | Jul 23, 2012 |
| Split Type | Forward |
| Split Ratio | 5:1 |
Scores
CME Group has an Altman Z-Score of 0.51 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.51 |
| Piotroski F-Score | 5 |